E M H Swiss Medical Publishers Ltd

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Drilon
    Drilon
  3. Koche
    Koche
  4. Rosenberg
    Rosenberg
  5. Sherman
    Sherman
  6. Yang
    Yang
  7. Modi
    Modi
  8. Morris
    Morris
  9. Cercek Hanjis
    Cercek Hanjis
  10. Landau
    Landau

Groups

  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (14)
  3. Center for Hematologic Malignancies (13)
  4. Center for Molecular Imaging and Biotechnology (13)
  5. GSK Faculty (13)
  6. Executive Committee, Center for Hematologic Malignancies (12)
  7. Hematologic Malignancies, Division of (12)
  8. Adult Leukemia (11)
  9. Human Oncology and Pathogenesis Program (11)
  10. Genitourinary Oncology Service (5)
Search Within
Formats
  1. Meeting Abstract (27)
  2. Journal Article (2)
Groups
  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (14)
  3. Center for Hematologic Malignancies (13)
  4. Center for Molecular Imaging and Biotechnology (13)
  5. GSK Faculty (13)
  6. Executive Committee, Center for Hematologic Malignancies (12)

More Groups

People
  1. Ross Levine (11)
  2. Alexander Drilon (4)
  3. Eric Sherman (3)
  4. Jonathan Rosenberg (3)
  5. Li Yang (3)
  6. Richard Koche (3)

More People

Years
  1. 2023 (4)
  2. 2022 (7)
  3. 2021 (5)
  4. 2020 (8)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Swiss Medical Weekly (29)

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 3 study of tucatinib, trastuzumab, and modified FOLFOX6 as first-line treatment in HER2+metastatic colorectal cancer (MOUNTAINEER-03, trial in progress)
    Meeting Abstract

    Fritsch, R.; Andre, T.; Bekaii-Saab, T.; Cercek, A.; Nakamura, Y.; Raghav, K.; Siena, S.; Strickler, J.; Van Cutsem, E.; Adelberg, D.; more...
    Swiss Medical Weekly (2023)

    Fulltext@MSK | Save
  • Role of ERK1/2 kinases in megakaryopoiesis, thrombopoiesis, platelet function and thrombosis in myeloproliferative neoplasms
    Meeting Abstract

    Albrecht, C.; Stivala, S.; Vokalova, L.; Knopp, T.; Angelillo-Scherrer, A.; Levine, R.; Neel, B.; Meyer, S.
    Swiss Medical Weekly (2023)

    Fulltext@MSK | Save
  • Growth differentiation factor 15, a potential biomarker and a therapeutic target in myeloproliferative neoplasms
    Meeting Abstract

    Uda, N. R.; Stüdle, C.; Müggler, A.; Ueltschi, O.; Brunner, M.; Silzle, T.; Joachim, W.; Leković, D.; Lee, S. J.; Vannucchi, A. M.; more...
    Swiss Medical Weekly (2023)

    Fulltext@MSK | Save
  • Long-term development of assisted suicide in Switzerland: Analysis of a 20-year experience (1999-2018)
    Journal Article

    Montagna, G.; Junker, C.; Elfgen, C.; Schneeberger, A. R.; Güth, U.
    Swiss Medical Weekly (2023)

    Fulltext@MSK | Save
  • Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial
    Meeting Abstract

    Kroiss, M.; Sherman, E.; Wirth, L. J.; Cabanillas, M. E.; Robinson, B.; Subbiah, V.; Drilon, A.; Godbert, Y.; Fasnacht, N.; Soldatenkova, V.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • PSMAfore: A phase 3 study comparing 177Lu-PSMA-617 treatment with change in androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC
    Meeting Abstract

    Lorch, A.; Berthold, D.; Burger, I.; Morris, M.; Sartor, O.; Chi, K.; de Bono, J.; Shore, N.; Crosby, M.; Dalal, D.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • PSMAddition: A phase 3 trial to compare treatment with 177Lu-PSMA-617 plus SOC versus SOC alone in patients with metastatic HSPC
    Meeting Abstract

    Berthold, D.; Tagawa, S.; Sartor, O.; Parker, C.; Saad, F.; Sakharova, O.; de Bono, J.; Feng, F.; Fizazi, K.; Morris, M.
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • EV-301 long-term outcomes: 24-month findings from phase 3 trial of enfortumab vedotin vs chemotherapy in previously treated advanced urothelial carcinoma
    Meeting Abstract

    Rosenberg, J.; Powles, T.; Sonpavde, G.; Loriot, Y.; Duran, I.; Lee, J.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Mamtani, R.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • AXL tyrosine kinase mediates escape from type II JAK2 inhibition in myeloproliferative neoplasms
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Brkic, S.; Stivala, S.; Yang, J. L.; Ghosh, N.; Passweg, J. R.; Angelillo-Scherrer, A.; Dirnhofer, S.; Levine, R. L.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • Single cell genotyping of matched stem/progenitor and mature blood cells in treatment naive and AZA-treated MDS and CMML reveals significant contribution of mutated clones to blood production
    Meeting Abstract

    Schnegg-Kaufmann, A.; Thoms, J. A.; Bhuyan, G. S.; Hampton, H. R.; Vaughan, L.; Rutherford, K.; Kakadia, P. M.; Lee, H. M.; Johansson, E. M.; Failes, T.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save

    • E M H Swiss Medical Publishers Ltd – authorized name for: